1 “... of pulmonary arterial hypertension (PAH) in adults...”

2 “... drug therapies for pulmonary arterial hypertension (PAH), and will examine their cost-effectiveness...”

3 “...Pulmonary arterial hypertension (PAH) is a chronic and progressive disease characterized...”

4 “... of pulmonary arterial hypertension (PAH) in adults...”

5 “...Pulmonary arterial hypertension (PAH) is a chronic and progressive disease characterized...”

6 “... drug therapies for pulmonary arterial hypertension (PAH), and will examine their cost-effectiveness...”

7 Subjects: “...Pulmonary Artery / physiopathology...”

8 “...Pulmonary arterial hypertension (PAH; also classified as Group 1 pulmonary hypertension [PH]) is a...”

9 “...Pulmonary arterial hypertension (PAH; also classified as Group 1 pulmonary hypertension [PH]) is a...”

10 “...Selexipag (Uptravi) for pulmonary arterial hypertension (WHO class II and III)...”

11 “...Selexipag (Uptravi) for pulmonary arterial hypertension (WHO class II and III)...”

12 “...-term treatment of idiopathic pulmonary arterial hypertension (PAH), heritable HPAH, PAH associated...”

13 “...-term treatment of idiopathic pulmonary arterial hypertension (PAH), heritable HPAH, PAH associated...”

14 “... for the treatment of pulmonary arterial hypertension...”

15 “... for the treatment of pulmonary arterial hypertension...”

16 “... histopathology studies suggest that CTEPH and primary pulmonary artery hypertension (PAH) share common pathways...”

17 “... histopathology studies suggest that CTEPH and primary pulmonary artery hypertension (PAH) share common pathways...”

18 “... of selexipag tablets for the treatment of pulmonary arterial hypertension (PAH) in adults (World Health...”

19 “... of selexipag tablets for the treatment of pulmonary arterial hypertension (PAH) in adults (World Health...”

20 “... of riociguat 0.5 mg, 1 mg, 1.5 mg, 2 mg, and 2.5 mg tablets for the treatment of pulmonary arterial...”